TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Nuvalent Inc (NUVL)

Healthcare Biotechnology
124.00 $
+0.0% vs. previous close
Closing price · As of: 21. Jul 2026

Nuvalent Inc (NUVL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 1,331 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Balance Sheet NUVL
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
442 425 732 708 675 1,189 1,142 1,106 1,041 980 1,413 1,331
437 420 726 699 666 1,180 1,132 1,087 1,020 957 1,392 1,308
71 88 335 99 78 369 146 121 127 116 262 160
431 413 720 692 658 1,168 1,118 1,073 1,006 943 1,372 1,287
21 29 32 33 38 68 72 95 101 135 164 157
21 29 32 33 38 51 54 75 75 89 91 81
8.1 9.8 9.3 13 7.4 16 5.2 26 13 22 30 22
421 396 701 675 637 1,121 1,070 1,011 940 845 1,248 1,174
-214 -248 -286 -331 -388 -472 -547 -632 -731 -854 -972 -1,082
57 57 62 64 65 66 71 72 72 72 75 79

Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?